Cart
0

Respiratory Infectious Disease Diagnostics Market by Test Type (Mechanical Tests, Imaging Tests, and In Vitro Diagnostics (IVD) Tests), Disease Type (Asthma, Chronic Obstructive Pulmonary Disease, Lung Cancer, and Tuberculosis), and End User (Hospitals, Clinical Laboratories, and Physician Offices): Global Opportunity Analysis and Industry Forecast, 2017-2023

Get 20% Free Customization In This Report
LI_184499
Pages: NA
Jan 2019 | 397 Views
 
Author's : NA
Tables: NA
Charts: NA
 

According to the World Health Organization (WHO), respiratory infectious diseases are the third leading cause of death and result in over all three million deaths per year across the world. These diseases include pneumonia, bronchitis, sinus infections, laryngitis, and others. During the diagnostics of respiratory diseases, doctor mainly focuses on breathing issues and X-ray or CT scan to check the lower respiratory tract. Sometimes, fluid and inflammation in the lungs is also checked.

Rise in prevalence of respiratory diseases, growth in adoption of advanced molecular techniques, increase in geriatric population, and initiatives taken by government and non-profile organization to minimize the incidence of infectious diseases drive the market. However, factors such as lack of awareness about diagnostic solution and high cost of laboratory testing restrain the market growth. Further, development of cost effective tools for the infectious disease diagnosis and growth in concern about the disease in low-income countries provide lucrative opportunities for the market growth during the forecast period.

The respiratory infectious disease diagnostics market is segmented based on test type, disease type, end user, and region. Based on test type, it is categorized into mechanical tests, imaging tests, and in vitro diagnostics (IVD) tests. Mechanical tests are further segmented into spirometry, peak flow test, blood gas test, pulmonary function test, and obstructive sleep apnea (OSA) diagnostic test. In vitro diagnostics (IVD) tests are further divided into point-of-care (POC) test, molecular diagnostic test, and other tests. On the basis of disease type, the market is classified into asthma, chronic obstructive pulmonary disease, lung cancer, tuberculosis, and other diseases. On the basis of end user, the market is divided into hospital, clinical laboratories, physician offices, and other end users. By geography, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in this market include Abbott Laboratories, Thermo Fisher Scientific Inc., Alere, Inc., Koninklijke Philips N.V., Cardinal Health, COSMED, Smiths Group plc, NIHON KOHDEN CORPORATION, Becton, Dickinson and Company, and F. Hoffmann-La Roche AG.

Key Benefits for Stakeholders

  • The study provides an in-depth analysis of the global respiratory infectious disease diagnostics market with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides information about the current and upcoming trends in the market from 2016 to 2023, which helps to determine the prevailing opportunities.
  • Comprehensive analysis of factors that drive and restrict the growth of the market is provided.
  • Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale are provided.
  • Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which help to understand the competitive outlook of the global respiratory infectious disease diagnostics market.

Respiratory Infectious Disease Diagnostics Market Key Segments:

By Test Type

  • Mechanical tests
    • Spirometry
    • Peak Flow Test
    • Blood Gas Test
    • Pulmonary Function Test
    • Obstructive Sleep Apnea (OSA) Diagnostic Test
  • Imaging Tests
  • In Vitro Diagnostics (IVD) Tests
    • Point-of-Care (POC) Test
    • Molecular Diagnostic Test
    • Other Tests

By Disease Type

  • Asthma
  • Chronic Obstructive Pulmonary Disease
  • Lung Cancer
  • Tuberculosis
  • Other Diseases

By End User

  • Hospitals
  • Clinical Laboratories
  • Physician Offices
  • Other End Users

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 RESPIRATORY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TEST TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. MECHANICAL TEST

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.2.3.1. Spirometry

4.2.3.1.1. Market size and forecast

4.2.3.2. Peak Flow Test

4.2.3.2.1. Market size and forecast

4.2.3.3. Blood Gas Test

4.2.3.3.1. Market size and forecast

4.2.3.4. Pulmonary Function Test

4.2.3.4.1. Market size and forecast

4.2.3.5. Obstructive Sleep Apnea (OSA) Diagnostic Test

4.2.3.5.1. Market size and forecast

4.3. IMAGING TEST

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. IN VITRO DIAGNOSTICS (IVD) TEST

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.4.3.1. Point-Of-Care (POC) Test

4.4.3.1.1. Market size and forecast

4.4.3.2. Molecular Diagnostic Test

4.4.3.2.1. Market size and forecast

4.4.3.3. Other Tests

4.4.3.3.1. Market size and forecast

Chapter: 5 RESPIRATORY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY DISEASE TYPE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. ASTHMA

5.2.1. Market size and forecast

5.3. CHRONIC OBSTRUCTIVE PULMONARY DISEASE

5.3.1. Market size and forecast

5.4. LUNG CANCER

5.4.1. Market size and forecast

5.5. TUBERCULOSIS

5.5.1. Market size and forecast

5.6. OTHERS

5.6.1. Market size and forecast

Chapter: 6 RESPIRATORY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. CLINICAL LABORATORIES

6.3.1. Market size and forecast

6.4. PHYSICIAN OFFICES

6.4.1. Market size and forecast

6.5. OTHERS

6.5.1. Market size and forecast

Chapter: 7 RESPIRATORY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION

7.1. OVERVIEW
7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.2.4. North America Respiratory Infectious Disease Diagnostics Market by Test Type
7.2.5. North America Respiratory Infectious Disease Diagnostics Market by Disease Type
7.2.6. North America Respiratory Infectious Disease Diagnostics Market by End User

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast

7.3.4. Europe Respiratory Infectious Disease Diagnostics Market by Test Type
7.3.5. Europe Respiratory Infectious Disease Diagnostics Market by Disease Type
7.3.6. Europe Respiratory Infectious Disease Diagnostics Market by End User

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. South Korea market size and forecast
7.4.3.6. Rest of Asia-Pacific market size and forecast

7.4.4. Asia-Pacific Respiratory Infectious Disease Diagnostics Market by Test Type
7.4.5. Asia-Pacific Respiratory Infectious Disease Diagnostics Market by Disease Type
7.4.6. Asia-Pacific Respiratory Infectious Disease Diagnostics Market by End User

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. Saudi Arabia market size and forecast
7.5.3.3. South Africa market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast

7.5.4. LAMEA Respiratory Infectious Disease Diagnostics Market by Test Type
7.5.5. LAMEA Respiratory Infectious Disease Diagnostics Market by Disease Type
7.5.6. LAMEA Respiratory Infectious Disease Diagnostics Market by End User

Chapter: 8 COMPANY PROFILES

8.1. ABBOTT LABORATORIES

8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments

8.2. THERMO FISHER SCIENTIFIC INC.

8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments

8.3. ALERE, INC.

8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments

8.4. KONINKLIJKE PHILIPS N.V.

8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments

8.5. CARDINAL HEALTH

8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments

8.6. COSMED

8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments

8.7. SMITHS GROUP PLC

8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments

8.8. NIHON KOHDEN CORPORATION

8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments

8.9. BECTON, DICKINSON AND COMPANY

8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments

8.10. F. HOFFMANN-LA ROCHE AG

8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments

 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request TOC/Sample

Request Customization

Request TOC/Sample

OR

Purchase Full Report of
Respiratory Infectious Disease Diagnostics Market

  • Online Only
  • $3456 $3111
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840 $3456
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370 $4833
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450 $5805
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995 $8096
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo